Second Sight Medical Products (EYES) stock Forecast for 2022 – 2026
Last update: 05-24-2022, 5:12Sector: Healthcare
The share price of Second Sight Medical Products, Inc. (EYES) now
What analysts predict:: $2.5
52-week high/low: $7.64 / $1.14
50/200 Day Moving Average: $1.417 / $2.211
This figure corresponds to the average price over the previous 50/200 days. For Second Sight Medical Products stocks, the 50-day moving average is the support level today.
For Second Sight Medical Products stocks, the 200-day moving average is the resistance level today.
Are you interested in Second Sight Medical Products, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Second Sight Medical Products stock price in 2022, 2023, 2024, 2025, 2026. How much will one Second Sight Medical Products share be worth in 2022 - 2026?
When should I take profit in Second Sight Medical Products stock? When should I record a loss on Second Sight Medical Products stock? What are analysts' forecasts for Second Sight Medical Products stock? What is the future of Second Sight Medical Products stock?
We forecast Second Sight Medical Products stock performance using neural networks based on historical data on Second Sight Medical Products stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Second Sight Medical Products stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Second Sight Medical Products shares. This happens once a day.
Historical and forecast chart of Second Sight Medical Products stock
The chart below shows the historical price of Second Sight Medical Products stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Second Sight Medical Products stock price can be found in the table below.
Long-term forecasts by years.
Second Sight Medical Products daily forecast for a month
Second Sight Medical Products Daily Price Targets
Second Sight Medical Products Stock Forecast 05-26-2022.
Pessimistic target level: 2.01
Optimistic target level: 2.16
Second Sight Medical Products Stock Forecast 05-27-2022.
Pessimistic target level: 2.04
Optimistic target level: 2.10
Second Sight Medical Products Stock Forecast 05-28-2022.
Pessimistic target level: 2.05
Optimistic target level: 2.15
Second Sight Medical Products Stock Forecast 05-29-2022.
Pessimistic target level: 2.03
Optimistic target level: 2.08
Second Sight Medical Products Stock Forecast 05-30-2022.
Pessimistic target level: 2.02
Optimistic target level: 2.10
Second Sight Medical Products Stock Forecast 05-31-2022.
Pessimistic target level: 2.00
Optimistic target level: 2.09
EYES (EYES) Monthly Stock Prediction for 2022
Second Sight Medical Products forecast for this year
Second Sight Medical Products Stock Prediction for Jun 2022
An downtrend is forecast for this month with an optimal target price of $1.77441. Pessimistic: $1.60. Optimistic: $1.92
Second Sight Medical Products Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $2.02407. Pessimistic: $1.70. Optimistic: $2.30
Second Sight Medical Products Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $1.94756. Pessimistic: $1.70. Optimistic: $2.18
Second Sight Medical Products Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $1.89849. Pessimistic: $1.69. Optimistic: $2.16
Second Sight Medical Products Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $2.08985. Pessimistic: $1.80. Optimistic: $2.25
Second Sight Medical Products Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $2.48045. Pessimistic: $2.11. Optimistic: $2.70
Second Sight Medical Products Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $2.60546. Pessimistic: $2.30. Optimistic: $2.88
Second Sight Medical Products (EYES) Monthly Stock Prediction for 2023
Second Sight Medical Products (EYES) Monthly Stock Prediction for 2024
Second Sight Medical Products (EYES) Monthly Stock Prediction for 2025
Second Sight Medical Products (EYES) Monthly Stock Prediction for 2026
Second Sight Medical Products information and performance
Second Sight Medical Products Inc designs, manufactures and markets implantable prostheses to create an artificial form of useful vision for the blind. Argus II System’s product treats external retinal degenerations such as retinitis pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include an implant and external components. Geographically, the company operates in the United States, Italy, China, and most of its revenue comes from the United States.
Second Sight Medical Products Address
12744 SAN FERNANDO ROAD, BLDG. 3, SYLMAR, CA, US
Market Capitalization: 58 326 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -31 371 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: N/A
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.719
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 109.53
Enterprise Value (EV) /Revenue
EV To EBITDA: 1.511
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 39409200
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Second Sight Medical Products (EYES) stock dividend
Second Sight Medical Products last paid dividends on 01/01/1970. The next scheduled payment will be on 01/06/2020. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.